Companies settle major EpiPen class action lawsuit

EpiPens are lifesavers, but prices spiked so high that families were forced to used expired medicine. Viatris - once called Mylan - announced it would settle a class-action lawsuit over the price increases for hundreds of millions of dollars. It’s awaiting a judge’s approval.